Virbac Corporation
Exhibit (a)(2)(B)
Virbac Corporation
0000 Xxxxxxx Xxxx.
Fort Worth, Texas 76137
September 8, 2006
Dear Stockholder:
As we informed you in our previous letter to you, dated
August 18, 2006, the Company has entered into a tender
offer and merger agreement with Virbac S.A., Interlab S.A.S. and
Labogroup Holding, Inc., pursuant to which Labogroup Holding,
Inc., an indirect wholly owned subsidiary of Virbac S.A., has
commenced an offer to purchase each share of the Company common
stock that it does not already own for $5.25 per share, net to
the sellers in cash.
Enclosed is a supplement to the Schedule 14D-9, describing
in further detail the reasons for the Special Committee’s
and Board of Directors’ conclusions, and, including the
written opinion of Xxxxxxxx, Xxxxx, Xxxxxx & Xxxxx Financial
Advisors, Inc. Also enclosed is a supplement to Labogroup
Holding Inc.’s Offer to Purchase which was originally dated
August 18, 2006.
If you need further information on how to tender your shares to
Labogroup Holding, Inc., please contact the Information Agent
for the offer to purchase, Xxxxxx & Co., Inc., at
(000) 000-0000.
On behalf of the management, the Special Committee and the Board
of Directors, we thank you for the support you have given to the
Company over the years.
| Very truly yours, | |
| XXXX X. XXXXXXXX | |
| President and Chief | |
| Executive Officer |
